Tweenvest Stocks

Burzynski Research Institute, Inc. (OTCPK: BZYR)

Health Care · Biotechnology · US

$0.01

+93.33% today · -66.5% 1Y

Burzynski Research Institute, Inc. (OTCPK: BZYR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.14M and employs 1 people.

Over the last twelve months the share price has lost 66.5%, trading between 0.00 and 0.05.

Tweenvest scores Burzynski Research Institute, Inc. across four factors: quality 12/100. Its strongest factor is quality.

BZYR price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.14M
Revenue (TTM)
P/E
EPS
-0.01
Dividend yield
Beta (5Y)
0.41
52-week high
$0.05
52-week low
$0.00
Avg volume (3M)
Shares outstanding
131.45M
Employees
1
Next earnings

About Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

ISIN
US1231591058
Founded
1977
Listed since
Jan 2, 1997
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$264.52-0.17%
Amgen Inc.NasdaqGS: AMGN$237.52B$443.82+1.02%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$146.72+0.41%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$547.58-0.09%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$834.55+0.06%
argenx SEENXTBR: ARGX$65.85B864.20-4.19%
Moderna, Inc.NasdaqGS: MRNA$57.92B$138.78-4.34%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.